Additional Information

Description

Medroxyprogesterone Acetate 150 mg/mL is a synthetic progestin used primarily for hormonal therapy in various clinical settings. It is a formulation intended for intramuscular injection, typically administered every three months for contraception or to manage conditions like abnormal uterine bleeding, endometriosis, or as part of hormone replacement therapy in postmenopausal women.

The drug acts through the progesterone receptor, mimicking the action of the natural hormone progesterone. By binding to these receptors, it regulates reproductive and menstrual functions, stabilizing the endometrium and reducing excessive bleeding. This makes it effective in the treatment of various gynecological disorders, including dysfunctional uterine bleeding and endometrial hyperplasia.

Administered via deep intramuscular injection, Medroxyprogesterone Acetate 150 mg/mL is absorbed slowly into the bloodstream, providing prolonged therapeutic effects with just a few injections per year. It is marketed in pre-filled syringes, offering convenience and reducing the risk of dosing errors.